Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple SclerosisGlobeNewsWire • 10/30/19
Biogen's and Alkermes' Vumerity gets FDA approval for MS; Biogen's stock surgesMarket Watch • 10/30/19
Alkermes plc's (ALKS) CEO Richard Pops on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/23/19
Alkermes plc (ALKS) CEO Richard Pops on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/25/19
Earnings Preview: Alkermes (ALKS) Q2 Earnings Expected to DeclineZacks Investment Research • 07/18/19
Alkermes plc (ALKS) CEO Richard Pops on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 04/25/19